Skip to main content
J&J medical device division announces new neurovascular business
7/26/2017

The medical device division of Johnson & Johnson unveiled its neurovascular business, Cerenovus, at the annual meeting of the Society of NeuroInterventional Surgery. The business, created from the company's recent acquisitions of brain aneurysm treatment device maker Pulsar Vascular and neurovascular therapy technology developer Neuravi, will concentrate on providing solutions for ischemic and hemorrhagic stroke.

Full Story: